Related Experiment Video
Updated: Sep 16, 2025

Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
Pilot randomized clinical trial examining use of very low nicotine content cigarettes during pregnancy in the United
Sarah H Heil1, Loren S Kock1, Roxanne F Harfmann1
1UVM Tobacco Center of Regulatory Science, University of Vermont, Burlington, VT, United States of America.
Objective:
Randomized controlled trials have shown that reducing the nicotine content of cigarettes decreases the number of cigarettes smoked per day (CPD) without engendering compensatory smoking. The present study examined whether those effects extend to smoking during pregnancy.
Methods:
Pregnant participants (≤25 weeks gestational age) in the U.S. with less than an Associate's degree and not planning to quit smoking were randomly assigned to smoke their usual brand (UB) cigarettes or very low nicotine content (VLNC) cigarettes (0.4 mg nicotine/g of tobacco) for 12 weeks. The primary outcome was total CPD at 12 weeks.
Results:
Baseline characteristics did not differ between conditions (14 UB, 16 VLNC), but smoking-related variables were indicative of heavy smoking and moderate-high nicotine dependence. Mean (±SE) total CPD at 12 weeks among completers (11 UB, 12 VLNC) did not differ between conditions (18.4 ± 2.3 and 16.3 ± 2.6, respectively), nor did it vary over time. VLNC cigarette use did not lead to compensatory smoking, greater withdrawal or craving, or any severe or serious adverse events, and birth outcomes were within normal ranges on average.
Conclusions:
Results suggest this sample of pregnant participants did not realize the same benefits of VLNC cigarettes that other not-pregnant samples have, although there was also no evidence of harm in the form of compensatory smoking or other adverse events. The sample's smoking characteristics suggest they were especially resistant to changing their smoking and it remains possible that those with more representative smoking patterns during pregnancy will respond to VLNC cigarettes as other populations have.
Clinicaltrials:
govID:NCT04033237.
More Related Videos
08:39Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
Published on: August 25, 2018
09:30A Microcontroller Operated Device for the Generation of Liquid Extracts from Conventional Cigarette Smoke and Electronic Cigarette Aerosol
Published on: January 18, 2018
Related Concept Videos
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...